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Abstract 
Background: Determining the source of malaria outbreaks in Ecuador and identifying remaining transmission 
foci will help in malaria elimination efforts. In this study, the genetic signatures of Plasmodium falciparum isolates, 
obtained from an outbreak that occurred in northwest Ecuador from 2012 to 2013, were characterized.
Methods: Molecular investigation of the outbreak was performed using neutral microsatellites, drug resistance mark‑
ers and pfhrp2 and pfhrp3 genotyping.
Results: A majority of parasite isolates (31/32) from this outbreak were of a single clonal type that matched a clonal 
lineage previously described on the northern coast of Peru and a historical isolate from Ecuador. All but one isolate 
carried a chloroquine‑resistant pfcrt genotype and sulfadoxine‑ and pyrimethamine‑sensitive pfdhps and pfdhfr geno‑
types. Pfmdr1 mutations were identified in codons 184 and 1042. In addition, most samples (97 %) showed presence 
of pfhrp2 gene.
Conclusions: This study indicates that parasites from a single clonal lineage largely contributed to this outbreak and 
this lineage was found to be genetically related to a lineage previously reported in the Peruvian coast and historical 
Ecuadorian parasites.
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Background
Some countries in Latin America have achieved and sur-
passed the goals set by the World Health Assembly for 
reducing malaria cases (reduction of malaria burden by 
75 % between 2000 and 2015) [1]. In particular, Ecuador 
has decreased the number of malaria cases from more 
than 100,000 (approximately 13.6 cases per 1000 indi-
viduals) in 2000 to 378 cases in 2013 (approximately 0.05 
cases per 1000 individuals), thus placing it in the pre-
elimination phase [1–3]. Nevertheless, outbreaks of both 
falciparum and vivax malaria still occur in both the Ama-
zon and Coastal regions of Ecuador.
Molecular tools are valuable in providing insight about 
the potential source of malaria parasites in outbreak 
investigations [4–8]. Neutral microsatellite markers, sin-
gle nucleotide polymorphism (SNP) based molecular bar-
codes and genomics tools have been used to characterize 
Plasmodium falciparum parasites in South America [5, 
9–17]. These studies have suggested that P. falciparum 
parasites in this region have undergone population bot-
tlenecks and in many parts of Peru and Colombia there 
are clonal population of parasites that are highly preva-
lent in different geographical regions.
One molecular investigation of P. falciparum isolates 
from Peru, using seven neutral microsatellite mark-
ers, revealed that the parasite isolates collected between 
1999 and 2000 (during peak malaria expansion after the 
malaria elimination era) comprised five distinct clonal 
lineages named A, B, C, D, and E [12]. In the coastal 
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region of Peru, all tested parasites belonged to the E 
clonal lineage while in the western region of the Peruvian 
Amazon, the C and D clonal lineages appeared more fre-
quently; in the eastern and central Amazon A, B, C and D 
clonal lineages were found [12]. It was proposed that C, 
D and E clonal lineages may have originated in Ecuador 
and Colombia while A and B clonal lineages may have 
originated in Brazil [11]. The profile of drug resistance 
markers among these clonal lineages also varied and, by 
combining drug resistance marker profiles and micro-
satellite allele information, it was possible to further 
understand the genetic relationship among these parasite 
lineages [7, 8, 12, 13, 17]. Recent studies suggest that Peru 
has the highest known proportion of pfhrp2 deleted P. 
falciparum parasites in the region, followed by Colombia 
and Suriname [14–16, 18]. Thus, by combining genetic 
markers such as neutral microsatellite markers, drug 
resistance markers and pfhrp2 gene presence or absence 
one might identify parasite lineages originating in this 
region as demonstrated in recent outbreak investigations 
in Peru [7, 8].
From November 2012 to November 2013, an outbreak 
of P. falciparum occurred in the city of Esmeraldas in the 
northwest of the country. One-hundred and fifty-one 
cases of P. falciparum were reported during this period 
in sharp contrast to previous years where no more than 
ten cases were reported annually (Fig. 1). Understanding 
the origins of malaria cases will be useful in developing 
strategies to prevent future outbreaks.
In order to understand the source of this outbreak par-
asite population the following questions were answered: 
(a) are these parasite populations genetically similar to 
parasite populations in Ecuador, Peru (southern border) 
and Colombia (northern border)? (b) is there any evi-
dence to suggest these parasites may have origins outside 
this region (Andean)? and (c) did these outbreak parasites 
belong to a single clonal lineage or to multiple lineages?
Methods
Ethics statement
The parasite samples used in this study were obtained 
from the malaria surveillance protocol approved by the 
Ethical Review Committee of Pontificia Universidad 
Católica del Ecuador. Written informed consent was pro-
vided by study participants and/or their legal guardians.
Study site
Esmeraldas city is the largest city in Esmeraldas Province 
in northwest Ecuador. All samples used in this study were 
collected in Esmeraldas city during a malaria outbreak 
that occurred between November 2012 and November 
2013.
Samples
The malaria outbreak occurred between November 
2012 and November 2013. Samples used in this study 
were collected from patients at 11 time points in 2013 
between epidemiological weeks 5 and 45, with a higher 
Fig. 1 Number of reported cases of Plasmodium falciparum per month in Esmeraldas city from 2008 to 2013 (data: Statistics Department, SNEM, 
Ministry of Public Health). An increase in the overall reported number of cases can be seen at the end of 2012 and during 2013
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concentration of samples collected in weeks 21–23 
(Fig.  2). Differences in sample collection patterns were 
due to logistical challenges, including lack of informed 
consent, lack of sample collection and delayed training 
of microscopists. A total of 32 blood samples collected 
from patients who were initially reported to be micro-
scopically positive for P. falciparum infection, and from 
whom informed consent was obtained, were available 
for this molecular investigation. The blood samples were 
collected by finger prick or by drawing peripheral whole 
blood and spotted on 3MM Whatman filter paper. All 
the samples were collected in Esmeraldas city between 
January and November 2013 and most (28 samples, 
87.5 %) came from the neighbourhoods in the southern 
part of the city where the majority of cases were reported 
(Fig. 3).
Reference isolates
In this study, laboratory adapted P. falciparum isolates 
3D7, Dd2 and HB3 were used as controls for genotyping. 
In addition, Ecu 1110, a P. falciparum culture-adapted 
strain that was originally isolated in Ecuador in 1990 
(provided by Dr Tom Wellems, National Institutes of 
Health, Bethesda, USA) was included as a reference 
strain from Ecuador.
DNA extraction and confirmation of infection
DNA was isolated from filter paper or whole blood using 
the QIAamp DNA mini-spin kit (QIAGEN, Valencia, 
CA, USA) or Chelex-100 [19]. Plasmodium falciparum 
infection status was further confirmed by two differ-
ent molecular methods: nested PCR using primers for 
18S ribosomal RNA [20], and photo-induced electron 
transfer (PET) real-time PCR using specific fluorogenic 
primers for Plasmodium (genus) and falciparum (spe-
cies) [21].
Detection of the pfhrp2 and pfhrp3 genes by PCR
Nested PCR amplifications of pfhrp2 and pfhrp3 genes 
were performed using reaction conditions and prim-
ers reported previously [15, 22]. In vitro cultured isolate 
Dd2 was used as a negative control for pfhrp2 amplifica-
tion experiments while HB3 served as a negative control 
for pfhrp3 amplification because the laboratory isolates 
lacked the respective genes. The resulting PCR ampli-
cons were visualized on a 2  % agarose gel. If a visible 
band of the appropriate size was observed, the isolate was 
scored as positive for the presence of the respective gene 
and that result was recorded as final. If no amplification 
occurred, PCR amplification was repeated to confirm 
this observation. If no amplification occurred during the 
second amplification attempt, thus showing concordance 
with the original PCR result, no further testing was done 
and the outcome was reported as negative. However, 
if there was discordance between the first and second 
result, the PCR was repeated again and the two matching 
results out of three were scored as the final result.
Microsatellite typing
Genomic DNA was used for microsatellite characteriza-
tion. Samples were genotyped for seven neutral micro-
satellite loci spanning six chromosomes that had been 
used in previous studies (TA1, chromosome 6; Polyα, ch. 
4; PfPK2, ch. 12; TA109, ch. 6; and 2490, ch. 10; C2M34, 
ch. 2; C3M69, ch. 3) [23–25]. Genomic DNA was ampli-
fied by PCR using previously described methods [12, 15, 
23–25] and fluorescently labelled (HEX and FAM) PCR 
products were separated by capillary electrophoresis on 
Fig. 2 Number of samples collected during the outbreak. The curve shows the total number of cases reported in each epidemiological week dur‑
ing 2013. The bars correspond to the number of samples collected in different epidemiological weeks that were used in this study. The samples 
available for molecular study were collected only at selected time points as indicated
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an Applied Biosystems 3130xl genetic analyzer (Applied 
Biosystems Foster City, CA, USA). Alleles were then 
sized and scored using GeneMapper v3.7 (Applied Bio-
systems Foster City, CA, USA) and binned to the nearest 
two or three base pairs.
Drug resistance markers
Sanger sequencing was performed on all samples to iden-
tify drug resistance-associated mutations in pfcrt, pfdhfr, 
pfdhps, and pfmdr1 genes [26]. Mutations in the codon 
positions 72–76 of pfcrt, 51, 59, 108, and 164 of pfdhfr, 
Fig. 3 Study area. a Esmeraldas Province and its location in Ecuador. Esmeraldas city is marked as a point in the coast of the province. b Map of 
Esmeraldas city. Most (28; 88 %) of the patient samples were collected from the neighbourhoods in the south of the city (black rectangle) which cor‑
responds to the area where most cases occurred
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436, 437, 540, 581, and 613 of pfdhps and 84, 134, 184, 
1034, 1042, 1226 and 1246 of pfmdr1 were identified.
Network analysis
A median-joining network diagram was generated in 
Network 4.6.1.3 [27] using the seven neutral microsatel-
lites previously described to examine the genetic relation-
ships among the 32 samples collected from the outbreak, 
in addition to Ecu 1110, the Peruvian historical isolates 
published previously [12] as well as five Colombian iso-
lates published recently [14].
Statistical analysis
Analysis of molecular variance (AMOVA) was used to 
partition variation within the study parasite population 
and between the population of Ecuador and falciparum 
populations of western Peru. In addition, heterozygosity 
(He) and pair-wise fixation indices (Fst) were calculated. 
Arlequin 3.5.1.2 software (CMPG, Swiss Institute of Bio-
informatics, Lausanne, Switzerland) was used for these 
analyses [28]. Structure v2.3.4 software [29, 30] was used 
to assign outbreak samples to previously known popula-
tions and Structure Harvester [31] was used to define the 
number of expected populations.
Results
During the P. falciparum malaria outbreak in Esmeraldas, 
151 cases of P. falciparum were identified (Fig. 1). Eighty 
per cent of the cases were located in two parishes in the 
south part of Esmeraldas. Men accounted for 57 % of the 
cases. Fifty per cent of the total number of cases were 
reported in teenagers and young adults (11–25 years old), 
while 13 % were in children 10 years old or younger, 22 % 
were in adults 25–40 years old and 15 % were in adults 
over 40  years old. Most cases were reported between 
February and April 2013, which corresponds to the rainy 
season on the Ecuadorian coast (Fig.  1). Thirty-two of 
these samples were available for this molecular investiga-
tion and were confirmed positive by nested PCR and real 
time PET-PCR.
Genetic characterization using microsatellite markers
Among the 32 samples tested, 31 showed similar micro-
satellite profile for all seven microsatellites, as indicated 
in Table  1. There were some minor variations in four 
samples. For instance, one locus (TA1) could not be 
amplified in sample F37 but the rest of the alleles were 
nearly identical to parasites of the E clonal lineage. Three 
of the samples (F3, F9 and F26) had extra alleles in locus 
C3M69 (122 bp) in addition to the shared genotype. With 
the exception of these minor variations, 31/32 isolates 
shared a very similar genetic profile corresponding to the 
E clonal lineage of Peru. One sample (F31) had a distinct 
genotype from all others, differing at four of seven loci. 
This isolate was similar to clonal lineage D in at least six 
of the seven loci tested (Table 1; Additional file 1).
As expected, heterozygosity in the Esmeraldas out-
break samples was very low (He = 0.0625) for most loci, 
consistent with a majority of isolates being clonal. Pair-
wise Fst was performed using the data from seven neutral 
microsatellite markers and compared with the five clonal 
lineages previously reported in Peru and four lineages 
reported in Colombia to determine their genetic related-
ness. As shown in Table 2, the Fst value between Peru’s 
E clonal lineage and the Esmeraldas outbreak popula-
tion was very close to zero, showing their close genetic 
relationship (P = 0.505). The pair-wise Fst with the other 
Peruvian clonal lineages and Colombian lineages were 
significantly higher (P = 0.00) (Table 2). To confirm the 
relatedness between the outbreak samples and clonal 
lineages E and D, a median joining network analysis was 
performed. The network analysis indicates that most of 
the samples are linked only to the coastal and Western 
Amazon parasites of Peru (clonal lineage E)  and to the 
clone Ecu 1110. In addition, five samples from Valle del 
Cauca in Colombia [14] were closely related to clonal 
lineage E and most outbreak samples. The exception was 
sample F31 which appears to be more closely related to 
clonal lineage D (Fig. 4). 
Drug resistance markers
All the samples obtained from the outbreak were tested 
by sequencing for single nucleotide polymorphisms 
(SNPs) in the anti-malarial drug resistance genes pfcrt, 
pfdhfr, pfdhps, and pfmdr1 (Table  3). All 31 samples 
that were related to the E clonal lineage carried the pfcrt 
genotype CVMNT (codon 72–76) while the singular D 
clonal lineage-related isolate, F31, had the CVMET geno-
type. The E clonal lineage-related 31 samples were wild 
type for all SNPs tested in the pfdhfr and pfdhps genes. 
Table 1 Microsatellite alleles amplified in isolates collected during the outbreak
a The clonal types of these parasites were comparable to previously described P. falciparum populations in Peru as demonstrated in Additional file 1
Clonal typea Number of samples TA1 Ch.6 Poly-α Ch.4 PfPK2 Ch.12 TA109 Ch.6 2490 Ch. 10 C2M34 Ch. 2 C3M69 Ch 3.
E 31 171 147 174 160 72 226 140
D 1 171 174 174 160 81 232 122
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Sample F31 (D clonal lineage) on the other hand, had the 
S108 N mutation in pfdhfr and a synonymous mutation 
in codon 540 of pfdhps. The Y184F mutation was found 
in the pfmdr1 gene of all 31 E clonal lineage parasites 
while the lone D clonal lineage parasite was wild type at 
this codon. In addition, all 32 samples had the mutation 
N1042D in pfmdr1. No mutations were found in any of 
these samples in codons 86, 130, 144, 1034, 1226, and 
1246 of pfmdr1 (Table 3; Additional file 2).
Pfhrp2 and pfhrp3 genotyping
The samples from this outbreak were genotyped for the 
presence of pfhrp2 and pfhrp3 genes. The results indi-
cated that both genes were intact in all 31 E clonal line-
age-related parasite isolates. In contrast, both pfhrp2 and 
pfhrp3 were deleted in the D clonal lineage isolate F31 
(Table 3).
Discussion
As Ecuador progresses towards the pre-elimination 
phase of the malaria control programme, it is impor-
tant to thoroughly investigate any malaria occurrences 
in the country. In this context, understanding the ori-
gins of a population of parasites during an outbreak 
will help the national programme to develop strategies 
for prevention of future outbreaks. The current molec-
ular epidemiologic investigation has determined that, 
with the exception of one parasite isolate, the isolates 
from the 2012–2013 outbreak that were tested carried 
a nearly identical genotypic profile which is related to 
the P. falciparum E clonal lineage parasites circulating 
on the north coast of Peru in 1999–2000. Interestingly, a 
Table 2 Pair-wise Fst of Esmeraldas outbreak samples ver-
sus  Peru samples by  clonal lineages [11] and  Colombian 
samples by clusters [15]
a The neutral microsatellite data reported for clonal lineages A to E (Peru) were 
obtained from previously published study for this analysis [11]. The neutral 
microsatellite data reported for Colombian parasites were obtained from 
previously published studies [14]
Clonal lineagea Sample size Esmeraldas (Ecu)
Esmeraldas (ECU) 32
A clonal lineage (PER) 24 0.90963
B clonal lineage (PER) 18 0.94465
C clonal lineage (PER) 26 0.87674
D clonal lineage (PER) 28 0.87538
E clonal lineage (PER) 34 −0.00085
Cluster 1 (COL) 21 0.57805
Cluster 2 (COL) 17 0.70054
Cluster 3 (COL) 26 0.47820
Cluster 4 (COL) 28 0.48890
Fig. 4 Network analysis of samples in this study and neighboring areas of Peru and Colombia. Network diagram showing genetic relationships 
among samples from Esmeraldas outbreak (2013), the Ecuadorian clone Ecu 1110 (1990), the coast and west Amazon of Peru (1999) (clonal line‑
ages D and E) as well as five related samples from the Coast of Colombia. The size of the circles represent the number of samples. A large majority of 
samples from the outbreak are closely related to samples from the north coast of Peru, some samples from the west Amazon of Peru and the coast 
of Colombia. Sample F31 is closely related to clonal lineage D of the West Amazon of Peru (also present in the East Amazon of Peru)
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single historical isolate collected in 1990 from the coast 
of Ecuador was also found to be similar to the E clonal 
lineage highlighting the historical connection between 
Peru and Ecuador in sharing a genetically similar pop-
ulation of parasites. These isolates also shared a similar 
drug resistance marker profile in pfcrt, pfdhfr, pfdhps, 
and pfmdr1 and had intact pfhrp2 and pfhrp3 genes. 
Interestingly, a single isolate collected in epidemiologi-
cal week 38 was found to be distinct from the rest of the 
outbreak isolates in its genetic profile and was related to 
another clonal lineage (D) that was reported previously 
in Peru (Fig. 5).
Overall, these findings suggest that the main source of 
this outbreak might be parasites belonging to the E clonal 
lineage. However, not all samples from this outbreak 
were available due to logistical challenges and the unwill-
ingness of some participants to provide consent. Since 
not all outbreak samples were available for molecular 
analysis, it was not possible to identify the genetic profile 
of all the parasite isolates, which would have helped to 
unambiguously describe the origin of the entire outbreak 
parasite population. Nevertheless, this finding clearly 
illustrates the utility of molecular epidemiological inves-
tigations in determining the origin(s) of outbreak parasite 
populations in future investigations as Ecuador moves 
towards malaria elimination.
The high clonality of P. falciparum observed in this 
low-transmission area is consistent with reports from 
Peru [12, 13, 32], Colombia [10, 14, 21] and Panama [5]. 
Using the same set of microsatellite markers used in this 
study, recent P. falciparum outbreaks in the north coastal 
region and Cusco area of Peru, were determined to have 
originated in a region of the Peruvian Amazon [7, 8]. A 
molecular epidemiological study conducted previously 
in the north coast of Peru determined that E clonal line-
age parasites were circulating in the 1990s [12]. Impor-
tantly, P. falciparum transmission was eliminated in the 
north coast of Peru from 2005 until the malaria outbreak 
of 2010–2012, during which a clonal population of para-
sites belonging to BV1 lineage from Peruvian Amazon, 
were introduced to the region [8]. These findings dem-
onstrate the utility of molecular tools for epidemiological 
investigations.
Since the genetic profile of P. falciparum parasites that were 
circulating in Ecuador is not known, it is difficult to clearly 
attribute whether the current major outbreak population 
Table 3 Drug resistance markers haplotypes and pfhrp2 and pfhrp3 presence
Pfcrt: 72–76
Pfdhfr: 50, 51, 59, 108, 164
Pfdhps: 436, 437, 540, 581, 613
Pfmdr1: 86,130, 144, 184, 1034, 1042, 1226, 1246
a Data as reported in [12]
b Data as reported in [34]
Number of  
samples
MS clonal  
type























Ecu 1110 1990b 1 E CVMNT CNCSI SAKAA NEDF SDFD + +
Fig. 5 Distribution of clonal lineages in Peru (12) and in Esmeraldas, 
Ecuador. Esmeraldas outbreak P. falciparum parasites from Ecuador 
share the same microsatellite haplotype as the Peruvian E clonal line‑
age but differ in some drug resistance markers
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expanded from a residual, vestigial population of parasites that 
may still be circulating in Ecuador. The finding that a single 
historical isolate from Ecuador collected about two decades 
ago genetically resembled the major outbreak population and 
that sporadic cases have been occurring in the area (Fig. 1) is 
consistent with the hypothesis that E clonal lineage-related P. 
falciparum strains were present in Ecuador throughout this 
time period. Based on this finding, one could argue for the 
possibility of a potential local expansion of residual reservoirs 
of parasites with E clonal genetic signatures in this outbreak 
due to some ecological changes. However, further genetic evi-
dence using parasite isolates collected in recent times from 
this region is needed to support such a hypothesis.
An alternative explanation for the source of this out-
break, based on epidemiological investigations, suggests 
that the migration of human cases between Colombia and 
Ecuador may be the cause of this outbreak (Ministry of 
Public Health of Ecuador, pers. comm.). However, there is 
no strong evidence to support this hypothesis as explained 
below. In a recent study, five parasite isolates closely 
related to the E clonal lineage were detected in sample col-
lections from 2008 and 2009 obtained from Valle de Cauca 
Department, Colombia. However, three of these parasites 
differed from this outbreak samples in the chromosomal 
10 locus 2490 and two differed in the chromosomal 6 locus 
TA109. While mostly CVMNK and CVMNT genotypes 
of pfcrt have been reported in Ecuador [33], Colombian 
parasites have been reported to be CVMET genotype [34]. 
Since there was no availability of parasite specimens from 
the index case(s), it was not possible to link the genetic 
data obtained with travel history information.
The F31 sample donor, who reported travel outside of 
the Esmeraldas area and worked in the Amazon region 
of Ecuador (Ministry of Public Health, pers. comm.), had 
parasites belonging to the D clonal lineage. Interestingly, 
this parasite isolate carried pfcrt genotype of CVMET 
that is characteristic of Colombian parasites, as docu-
mented in previous studies [34, 35]. Based on the travel 
history and pfcrt genotype, one can hypothesize that 
this traveler may have acquired the D lineage parasites 
from Colombia or the Ecuador Amazon region; however, 
information about the genetic profile of P. falciparum 
parasites circulating in the Ecuadorian Amazon is lacking 
and so in order to validate the hypothesis, P. falciparum 
genotype data will need to be collected from the region.
Ecuador changed its P. falciparum anti-malarial treatment 
policy in 2006, switching from chloroquine (CQ) to artesu-
nate-sulfadoxine-pyrimethamine (AS-SP) and recently to 
artemether-lumefantrine (AL) [33, 36]. It is important to 
note that even though the P. falciparum parasites from the 
outbreak have a CQ-resistant haplotype (CVMNT and 
CVMET), they carried wild type dhfr and dhps gentotypes 
associated with SP sensitivity. Mutations in pfmdr1 were 
restricted to only two codons as opposed to mutations in 
three or four codons of this gene in parasite isolates from 
the Amazon region of South America [13, 37]. Remark-
ably, the most common haplotype found in the Esmeraldas 
outbreak had the exact same drug resistance gene profile 
as Ecu 1110 [34, 35, 38], an isolate collected in Ecuador in 
1990. These results suggest that if these outbreak parasites 
are from the local residual transmission foci then they have 
maintained the historical CQ-resistant haplotype CVMNT 
in the population. In addition, the profile of wild type pfdhr 
and pfdhps alleles including the limited mutation pattern in 
pfmdr1 in the E clonal outbreak parasites indicates that this 
is an ancestral lineage that may predate SP introduction.
The clonal population from the Esmeraldas outbreak 
does not have deletions of pfhrp2 or pfhrp3, which 
would imply that these parasites can be detected by 
PfHRP2-based rapid diagnostic tests (RDTs). However, 
the D clonal lineage-related F31 sample had deleted both 
pfhrp2 and pfhrp3. This finding highlights the need for 
vigilance when PfHRP2-based RDTs are used for control 
programmes in South America since pfhrp2 deletion has 
been documented in parts of South America [14–16, 18].
Conclusions
Taken together, this data suggest that the P. falciparum 
isolates from the Esmeraldas outbreak are the result of 
a clonal expansion of parasites either circulating at very 
low levels in Ecuador or re-invading Ecuador from border 
countries. Some of the limitations of this study include 
the lack of genetic and travel information from the index 
case(s), lack of population-level genotypic data for P. fal-
ciparum parasites in Ecuador and the availability of only 
a sub-set of samples from the outbreak for analysis. Nev-
ertheless, this study highlights the importance of molec-
ular studies to investigate the origin and relatedness of 
Plasmodium parasite populations in outbreak investi-
gations. Further genetic characterization of historical 
malaria parasites from Ecuador will help in determining 
if low-level transmission of bottle-necked, vestigial popu-
lations of historical Ecuadorian parasites still contribute 
to local malaria transmission. The genetic characteriza-
tions will also help in future outbreak investigations to 
differentiate residual bottle-necked populations from 
newly introduced parasites from other regions as efforts 
are underway to eliminate malaria from this region.
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Additional file 2. Drug resistance haplotypes and pfhrp2 and pfhrp3 
presence in the study samples.
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